Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Eckert & Ziegler Strahlen und Medizintechnik (EUZ) Stock Price & Analysis

EUZ Stock Chart & Stats

CHF 11.56CHF 0.00(0.00%)
At close: 5:30 PM GMT+1
CHF11.5CHF12CHF12.5CHF133 Aug9 Sep5 Oct
Day’s Range
CHF 11.56 - CHF 12.27
52-Week Range
CHF 11.24 - CHF 13.09
Previous Close
CHF 11.56
Volume
0
Average Volume (3M)
10
Market Cap
CHF 766.70M
Enterprise Value
CHF 892.81M
Total Cash (Recent Filing)
CHF 110.33M
Total Debt (Recent Filing)
CHF 41.04M
Price to Earnings (P/E)
16.6
Beta
0.90
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
1.77%

Bulls Say, Bears Say

Bulls Say

Strong Profitability

Strong gross, operating, and net margins indicate that the company converts revenue into profit efficiently across its medical technology and isotope activities. Sustained profitability supports internal reinvestment, resilience against operating pressure, and the ability to fund growth without relying heavily on external capital.

Conservative Balance Sheet

Low leverage gives Eckert & Ziegler meaningful financial flexibility and reduces the burden of debt service during weaker periods. Growing equity and strong returns on that capital indicate a sturdy balance sheet that can support investment, absorb volatility, and preserve strategic options.

Positive Cash Generation

The company generates substantial operating cash and remains free-cash-flow positive, providing internally generated funding for capital needs and business development. This cash generation complements the low-leverage balance sheet and supports financial resilience over the next several quarters.

Bears Say

Softening Revenue Growth

The recent TTM revenue decline suggests that the company’s top-line momentum has softened after several years of expansion. If this persists, slower growth could limit operating leverage, reduce the pace of earnings expansion, and make continued margin performance more dependent on execution.

Moderate Cash Conversion

Cash conversion is below reported earnings, meaning accounting profitability is not fully translating into operating and free cash flow. Over time, this can constrain internally funded investment and make earnings quality more dependent on improvements in working capital or other non-cash items.

Declining Free Cash Flow

A roughly 19% TTM decline in free cash flow weakens the company’s financial momentum even though cash generation remains positive. Continued pressure could reduce flexibility for investment, shareholder returns, or strategic initiatives, particularly if revenue growth remains subdued.

Eckert & Ziegler Strahlen und Medizintechnik News

EUZ FAQ

What was Eckert & Ziegler Strahlen und Medizintechnik’s price range in the past 12 months?
Eckert & Ziegler Strahlen und Medizintechnik lowest stock price was CHF11.24 and its highest was CHF13.09 in the past 12 months.
What is Eckert & Ziegler Strahlen und Medizintechnik’s market cap?
Eckert & Ziegler Strahlen und Medizintechnik’s market cap is CHF766.70M.
When is Eckert & Ziegler Strahlen und Medizintechnik’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eckert & Ziegler Strahlen und Medizintechnik’s earnings last quarter?
Eckert & Ziegler Strahlen und Medizintechnik released its earnings results on Aug 13, 2026. The company reported CHF0.177 earnings per share for the quarter.
Is Eckert & Ziegler Strahlen und Medizintechnik overvalued?
According to Wall Street analysts Eckert & Ziegler Strahlen und Medizintechnik’s price is currently Undervalued.
Does Eckert & Ziegler Strahlen und Medizintechnik pay dividends?
Eckert & Ziegler Strahlen und Medizintechnik does not currently pay dividends.
What is Eckert & Ziegler Strahlen und Medizintechnik’s EPS estimate?
Eckert & Ziegler Strahlen und Medizintechnik’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eckert & Ziegler Strahlen und Medizintechnik have?
Eckert & Ziegler Strahlen und Medizintechnik has 63,515,797 shares outstanding.
What happened to Eckert & Ziegler Strahlen und Medizintechnik’s price movement after its last earnings report?
Eckert & Ziegler Strahlen und Medizintechnik reported an EPS of CHF0.177 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Eckert & Ziegler Strahlen und Medizintechnik?
Currently, no hedge funds are holding shares in CH:EUZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology